산텐제약(주) - 예수탁증서(보통주): 손익 계산서 (TTM)

산텐제약(주) - 예수탁증서(보통주)
US ˙ OTCPK ˙ US80287P1003

손익 계산서 (TTM)

산텐제약(주) - 예수탁증서(보통주) 손익 계산서(Income Statement)에는 일정 기간 동안의 소득 및 지출 변화가 표시됩니다. 손익 계산서 데이터에는 판매액(Sales), 매출액(Revenue), 총이익(Gross Profit), 연구개발(R&D), 판매 및 관리비(SG&A: Selling, General and Administrative Expense), 영업이익(Operating Income), 소득세 비용, 이자 비용, 비영업이익, 주당이익(EPS: Earnings per Share) 및 발행 주식수로 구성됩니다.

모든 수치는 지분 단위당 1,000,000 제외의 곱입니다.123456

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
수익 257,028 259,459 263,620 266,257 266,804 266,413 270,242 279,037 285,893 295,928 302,084 301,965 304,347 302,563 301,905 300,004 293,970 291,479 287,994 291,624
변화 (%) 0.95 1.60 1.00 0.21 -0.15 1.44 3.25 2.46 3.51 2.08 -0.04 0.79 -0.59 -0.22 -0.63 -2.01 -0.85 -1.20 1.26
수익의 % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
매출원가 100,404 101,383 105,028 109,671 111,153 112,705 112,416 112,950 114,568 116,504 119,101 123,256 125,237 127,308 129,298 128,977 128,391 126,149 123,949 121,881
변화 (%) 0.98 3.60 4.42 1.35 1.40 -0.26 0.48 1.43 1.69 2.23 3.49 1.61 1.65 1.56 -0.25 -0.45 -1.75 -1.74 -1.67
수익의 % 39.06 39.07 39.84 41.19 41.66 42.30 41.60 40.48 40.07 39.37 39.43 40.82 41.15 42.08 42.83 42.99 43.67 43.28 43.04 41.79
총 영업 이익 156,624 158,076 158,592 156,586 155,651 153,708 157,826 166,087 171,325 179,424 182,983 178,709 179,110 175,255 172,607 171,027 165,579 165,330 164,045 169,743
변화 (%) 0.93 0.33 -1.26 -0.60 -1.25 2.68 5.23 3.15 4.73 1.98 -2.34 0.22 -2.15 -1.51 -0.92 -3.19 -0.15 -0.78 3.47
수익의 % 60.94 60.93 60.16 58.81 58.34 57.70 58.40 59.52 59.93 60.63 60.57 59.18 58.85 57.92 57.17 57.01 56.33 56.72 56.96 58.21
판매관리비 118,482 119,996 121,088 120,610 119,590 123,254 125,789 134,072 135,711 134,950 133,319 91,529 87,583 86,310 87,223 83,511 87,092 83,813 87,349 89,570
변화 (%) 1.28 0.91 -0.39 -0.85 3.06 2.06 6.58 1.22 -0.56 -1.21 -31.35 -4.31 -1.45 1.06 -4.26 4.29 -3.76 4.22 2.54
수익의 % 46.10 46.25 45.93 45.30 44.82 46.26 46.55 48.05 47.47 45.60 44.13 30.31 28.78 28.53 28.89 27.84 29.63 28.75 30.33 30.71
연구개발 504 1,215 1,150 979 1,929 2,879 -798 -1,806 -3,474 25,416 24,619 23,899 23,981 24,103 24,606 25,530 25,502 26,185
변화 (%) 141.07 -5.35 97.04 49.25 126.32 92.36 -831.61 -3.14 -2.92 0.34 0.51 2.09 3.76 -0.11 2.68
수익의 % 0.20 0.47 0.44 0.37 0.72 1.07 -0.28 -0.61 -1.15 8.42 8.09 7.90 7.94 8.03 8.37 8.76 8.86 8.98
운영 비용 202,380 205,832 211,001 230,382 231,751 268,364 270,893 243,737 246,177 216,509 220,479 263,425 251,756 251,604 250,682 251,709 250,271 249,142 245,690 243,826
변화 (%) 1.71 2.51 9.19 0.59 15.80 0.94 -10.02 1.00 -12.05 1.83 19.48 -4.43 -0.06 -0.37 0.41 -0.57 -0.45 -1.39 -0.76
수익의 % 78.74 79.33 80.04 86.53 86.86 100.73 100.24 87.35 86.11 73.16 72.99 87.24 82.72 83.16 83.03 83.90 85.13 85.48 85.31 83.61
영업 이익 54,648 53,627 52,619 35,875 35,053 -1,951 -651 35,300 39,716 79,419 81,605 38,540 52,591 50,959 51,223 48,295 43,699 42,337 42,304 47,798
변화 (%) -1.87 -1.88 -31.82 -2.29 -105.57 -66.63 -5,522.43 12.51 99.97 2.75 -52.77 36.46 -3.10 0.52 -5.72 -9.52 -3.12 -0.08 12.99
수익의 % 21.26 20.67 19.96 13.47 13.14 -0.73 -0.24 12.65 13.89 26.84 27.01 12.76 17.28 16.84 16.97 16.10 14.87 14.52 14.69 16.39
이자 비용 -249 -249 -95 -224 -476 -521 -754 -748 -2,664 -1,070 -1,596 -1,166 -1,083 -3,058 -1,204 -2,882 -1,994
변화 (%) -61.85 112.50 9.45 44.72 -0.80 256.15 -59.83 49.16 -26.94 -7.12 182.36 -60.63 139.37 -30.81
수익의 % -0.10 -0.09 -0.04 -0.08 -0.17 -0.18 -0.25 -0.25 -0.88 -0.35 -0.53 -0.39 -0.36 -1.04 -0.41 -1.00 -0.68
당기순이익 7,983 7,324 5,062 27,218 26,539 -9,130 -8,195 -14,948 -11,197 26,374 27,729 26,642 26,861 26,133 27,494 36,256 31,501 31,424 30,607 37,369
변화 (%) -8.26 -30.88 437.69 -2.49 -134.40 -10.24 82.40 -25.09 -335.55 5.14 -3.92 0.82 -2.71 5.21 31.87 -13.12 -0.24 -2.60 22.09
수익의 % 3.11 2.82 1.92 10.22 9.95 -3.43 -3.03 -5.36 -3.92 8.91 9.18 8.82 8.83 8.64 9.11 12.09 10.72 10.78 10.63 12.81

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista